Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Julie M. Lade
Human Biotransformation of the Nonnucleoside Reverse Transcriptase Inhibitor Rilpivirine and a Cross-Species Metabolism Comparison
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Fraction Unbound for Liver Microsome and Hepatocyte Incubations for All Major Species Can Be Approximated Using a Single Species Surrogate
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Related publications
Minority Variants Associated With Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Selection of Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutations in HIV-1 Subtype C: Evidence of Etravirine Cross-Resistance
AIDS
Infectious Diseases
Allergy
Immunology
Novel Mutations L228I and Y232H Cause Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Combinational Pattern
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
In Vitro Microbicidal Activity of the Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) UC781 Against NNRTI-Resistant Human Immunodeficiency Virus Type 1
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor Through Use of Population Pharmacokinetic Modeling and Monte Carlo Simulation
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Human Immunodeficiency Virus Reverse Transcriptase Substrate-Induced Conformational Changes and the Mechanism of Inhibition by Nonnucleoside Inhibitors.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
In Vitro Evaluation of Nonnucleoside Reverse Transcriptase Inhibitors UC-781 and TMC120-R147681 as Human Immunodeficiency Virus Microbicides
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology